Supplementary Provisions, Article 2Review
第二条(検討)
After the promulgation of this Act, from the viewpoint of realizing a sustainable medical insurance system, the government is to promptly examine further reforms to ensure the appropriate implementation of necessary insurance benefits, etc. and fairness of burdens between and within generations, in response to changes in the socioeconomic situation and the needs of society, and take required measures based on the results.
政府は、この法律の公布後において、持続可能な医療保険制度を実現する観点から、社会経済情勢の変化及び社会の要請に対応し、必要な保険給付等の適切な実施並びに世代間及び世代内の負担の公平性の確保を図るための更なる改革について速やかに検討を加え、その結果に基づいて所要の措置を講ずるものとする。
The government is to, with regard to the provisions of Article 63, paragraph (2), item (vi) and Article 86, paragraph (3), item (i) of the Health Insurance Act as amended by the provisions of Article 1 (limited to the amending provisions set forth in item (iv) of the preceding Article; the same applies in paragraph (1) of the following Article and Article 11 of the Supplementary Provisions) and the provisions of Article 64, paragraph (2), item (vi) and Article 76, paragraph (3), item (i) of the Act on Assurance of Medical Care for Elderly People as amended by the provisions of Article 8 (limited to the amending provisions set forth in item (iv) of the preceding Article; the same applies in paragraph (2) of the following Article and Article 25 of the Supplementary Provisions), examine how the Minister of Health, Labour and Welfare is to make determinations under those provisions, etc., taking into account the conditions of efforts to deepen the understanding of the public concerning the taking of pharmaceuticals requiring guidance (meaning a pharmaceutical requiring guidance prescribed in Article 4, paragraph (5), item (iii) of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (Act No. 145 of 1960); the same applies hereinafter in this paragraph) and over-the-counter pharmaceuticals (meaning an over-the-counter pharmaceutical prescribed in item (iv) of that paragraph) pertaining to minor illnesses, etc. (hereinafter in this paragraph referred to as "pharmaceuticals requiring guidance, etc.") and to deepen the understanding of physicians, dentists and pharmacists concerning pharmaceuticals requiring guidance, etc., and the conditions of conversion into pharmaceuticals requiring guidance of pharmaceuticals that are to be used by a physician or dentist or used upon the issuance of a prescription by such a person, etc., and take required measures based on the results.
政府は、第一条の規定(前条第四号に掲げる改正規定に限る。次条第一項及び附則第十一条において同じ。)による改正後の健康保険法第六十三条第二項第六号及び第八十六条第三項第一号の規定並びに第八条の規定(前条第四号に掲げる改正規定に限る。次条第二項及び附則第二十五条において同じ。)による改正後の高齢者の医療の確保に関する法律第六十四条第二項第六号及び第七十六条第三項第一号の規定について、軽度の疾病等に係る要指導医薬品(医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律(昭和三十五年法律第百四十五号)第四条第五項第三号に規定する要指導医薬品をいう。以下この項において同じ。)及び一般用医薬品(同項第四号に規定する一般用医薬品をいう。)(以下この項において「要指導医薬品等」という。)の服用に関する国民の理解並びに要指導医薬品等に関する医師、歯科医師及び薬剤師の理解を深めるための取組の状況、医師若しくは歯科医師によって使用され又はこれらの者の処方箋の交付を受けて使用すべき医薬品に係る要指導医薬品への転用に係る状況等を勘案し、これらの規定に係る厚生労働大臣の定めの在り方等について検討し、その結果に基づいて所要の措置を講ずるものとする。
In addition to the matters specified in the preceding paragraph, the government is to, with a target of five years after the enforcement of this Act, taking into account the conditions of enforcement, etc. of the respective Acts as amended by this Act (referred to as "the respective Acts as amended" in this paragraph), examine the provisions of the respective Acts as amended where it finds it necessary, and take required measures based on the results.
前項に定める事項のほか、政府は、この法律の施行後五年を目途として、この法律による改正後のそれぞれの法律(以下この項において「改正後の各法律」という。)の施行の状況等を勘案し、必要があると認めるときは、改正後の各法律の規定について検討を加え、その結果に基づいて所要の措置を講ずるものとする。